|
Apr 15
|
Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke
|
|
Apr 14
|
Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?
|
|
Apr 14
|
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and Novartis
|
|
Apr 11
|
Novartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key Medicines
|
|
Apr 11
|
NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat
|
|
Apr 11
|
Novartis commits $23bn to US manufacturing amid tariff threats
|
|
Apr 11
|
Pharma Stock Roundup: EU Nod to Expanded Use of ABBV, AZN Drugs & More
|
|
Apr 11
|
Novartis Stock Rises After Swiss Drugmaker Promises to Boost U.S. Manufacturing
|
|
Apr 11
|
Sector Update: Health Care Stocks Mixed Premarket Friday
|
|
Apr 11
|
This Pharma Giant Will Invest $23 Billion in the U.S. It’s a Sign Trump’s Tariffs Are Working.
|
|
Apr 10
|
Novartis Plans $23B Investment in US Facilities as Trump Threatens Pharma Tariffs
|
|
Apr 10
|
Swiss Drugmaker Novartis Promises to Boost U.S. Manufacturing Amid Tariff Threats
|
|
Apr 10
|
Novartis to spend $23B to expand in the US
|
|
Apr 10
|
Update: Market Chatter: Novartis Plans to Spend $23 Billion to Build, Expand 10 US Facilities
|
|
Apr 10
|
Amid tariff turmoil, Novartis commits to spending $23B on US manufacturing
|
|
Apr 10
|
Novartis plans to invest $23 billion in US sites as Trump renews drug tariff threats
|
|
Apr 9
|
Trending tickers: Apple, Advanced Micro Devices, Ford, BP and AstraZeneca
|
|
Mar 14
|
Alnylam Rallies 62% in a Year: Can the Stock Maintain This Momentum?
|
|
Mar 12
|
Q4 2024 Legend Biotech Corp Earnings Call
|
|
Feb 23
|
Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts
|